comparemela.com

Latest Breaking News On - Deepak nath - Page 19 : comparemela.com

Smith & Nephew Q1 revenues grow, reiterates FY guidance

Medical equipment manufacturer Smith & Nephew reiterated its full-year guidance on Wednesday after seeing revenues improve in the first quarter.

Journo Found Dead Under Peculiar Conditions

CITY WHISPERS: Is Revolut still banking on its licence any time soon?

It s nearly a fortnight since Revolut said it could receive a UK banking licence any day now . Imminently was another word used when the company unveiled its first profit on March 1.

It may not be sprinting ahead, but Smith & Nephew is still in the race – so don t write it off

Questor share tip: the orthopaedics, wound care and sports medicines specialist is well placed to make the most of the decline of Covid

Smith & Nephew (LON:SN) Upgraded to Buy at Liberum Capital

Smith & Nephew (LON:SN – Get Rating) was upgraded by investment analysts at Liberum Capital to a “buy” rating in a research report issued on Wednesday, LSE.Co.UK reports. The firm currently has a GBX 1,410 ($17.01) target price on the stock, up from their previous target price of GBX 1,120 ($13.52). Liberum Capital’s target price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.